As a leading N-[4-[2-(2-Amino-4,7-Dihydro-4-Oxo-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Ethyl]Benzoyl]L-Glutamic Acid,1,5-Diethyl Ester,4-Methylbenzenesulfonate(1:1) supplier, we deliver high-quality products across diverse grades to meet evolving needs, empowering global customers with safe, efficient, and compliant chemical solutions.
What is the chemical structure of N- [4- [2- (2-amino-4,7-dihydro-4-oxo-3H-pyrrolido [2,3-d] pyrimidine-5-yl) ethyl] benzoyl] -L-glutamic acid, 1,5-diethyl ester, 4-methylbenzenesulfonate (1:1)
The naming of this compound is complicated, and its structure can be analyzed step by step. "N- [4- [2- (2-hydroxy-4,7-dioxo-4-oxo-3H-pyrazolo [2,3-d] pyrimidine-5-yl) ethyl] phenyl] -L-glutamic acid, 1,5-diethyl ester, 4-methylbenzenesulfonate (1:1) ".
First, starting from the core structure, "3H-pyrazolo [2,3-d] pyrimidine" is a cyclic structure with many substituents on it. " 2-Hydroxy-4,7-dioxo-4-oxo "indicates the presence of hydroxyl and oxo groups at specific positions, which affect the electron cloud distribution and chemical activity of the compound." 5-yl) ethyl] phenyl "indicates that this ring system is connected by ethyl and phenyl, expanding the conjugation system of molecules.
"N - [4- [2- (2-hydroxy-4,7-dioxo-4-oxo-3H-pyrazolo [2,3-d] pyrimidine-5-yl) ethyl] phenyl]" is attached to the nitrogen atom of L-glutamic acid as a whole as a substituent. L-glutamic acid itself has a carboxyl and amino group, which is an amino acid structure and is an important part of the molecule here.
"1,5-diethyl ester" indicates that the carboxyl groups at the 1st and 5th positions of L-glutamic acid are esterified to form an ethyl ester structure, which changes the solubility and stability of the molecule.
"4-methylbenzenesulfonate (1:1) " means that the compound binds to 4-methylbenzenesulfonate in a ratio of 1:1, which may be connected by ionic bonds or other interactions, affecting the physicochemical properties of the compound.
To sum up, this compound has a complex structure and the interaction of various parts, which together determine its unique chemical properties and potential biological activities.
What is the main use of N- [4- [2- (2-amino-4,7-dihydro-4-oxo-3H-pyrrolido [2,3-d] pyrimidine-5-yl) ethyl] benzoyl] -L-glutamic acid, 1,5-diethyl ester, 4-methylbenzenesulfonate (1:1)
The full name of this compound is long and complex. In practical applications, it is mainly used in the field of medicinal chemistry due to its unique chemical structure and characteristics. In the process of drug development, it can serve as a key lead compound. With subtle modification and optimization of its structure, scientists can create new drugs with better efficacy and milder side effects.
For example, in the research and development of anti-tumor drugs, the compound can precisely act on key targets of tumor cells or interfere with the signaling pathways of tumor cells, thereby effectively inhibiting the proliferation and spread of tumor cells. For example, in the exploration of drugs for treating diseases of the nervous system, it may be able to regulate the release and transmission of neurotransmitters and improve the function of the nervous system.
In addition, in the field of organic synthetic chemistry, it can be used as an extremely important intermediate. With the help of a series of chemical reactions, it can be converted into organic compounds with diverse functions and structures, providing a rich material basis for the development of organic synthetic chemistry and promoting the progress of new organic materials and other fields.
What are the physical properties of N- [4- [2- (2-amino-4,7-dihydro-4-oxo-3H-pyrrolido [2,3-d] pyrimidine-5-yl) ethyl] benzoyl] -L-glutamic acid, 1,5-diethyl ester, 4-methylbenzenesulfonate (1:1)
This substance is a complex organic compound chemically synthesized, and its chemical name is lengthy and contains specific structures and group descriptions. Under the paradigm of "Tiangongkai", its physical properties are described in ancient Chinese as follows:
The appearance of this compound may have a unique morphology, or be in a crystalline state, with a regular crystal form, luster or warm like jade, or dull like stone, depending on the preparation method and purity. Its texture may be brittle and fragile, like glaze, which is easily broken into pieces when hit by external force; or it has a certain toughness, which can be bent slightly and continuously broken, but excessive force will also cause it to break.
As far as solubility is concerned, it may be partially soluble in common organic solvents, but more insoluble in water, just like oil floating in water, and it is distinct. This is due to the characteristics of groups in the molecular structure, most of which are hydrophobic and lipophilic.
Its melting point may be quite high, and it needs to be roasted with a hot fire to reach a considerable temperature before melting. When melting, there may be smoke rising, accompanied by a special smell, or fragrant or smelly, which is caused by the thermal decomposition and volatilization of atoms and groups in the molecule.
The density is relatively ordinary, either light or heavy, depending on the type of atoms in the molecule and the degree of close arrangement. If the atomic weight is high and the arrangement is dense, the density is higher, and it is placed in water to sink to the bottom; if the atomic weight is light and the structure is loose, the density is small, or it can float on a specific liquid.
What is the preparation method of N- [4- [2- (2-amino-4,7-dihydro-4-oxo-3H-pyrrolo [2,3-d] pyrimidine-5-yl) ethyl] benzoyl] -L-glutamic acid, 1,5-diethyl ester, 4-methylbenzenesulfonate (1:1)
To prepare N - [4 - [2 - (2 - hydroxy - 4,7 - dioxo - 4 - oxo - 3H - imidazolo [2,3 - d] pyrimidine - 5 - yl) ethyl] benzyl] - L - glutamic acid, 1,5 - diethyl ester, 4 - methyl benzyl ester (1:1), can be as follows:
starting material containing the corresponding substituent pyrimidine and benzyl derivatives, supplemented by diethyl glutamate. First, the active check point of the pyrimidine derivative is deprotonated with an appropriate base, and then nucleophilic substitution is carried out with the benzyl derivative containing the substituent. In this process, the reaction temperature and time need to be controlled to ensure that the reaction is moderate and side reactions are avoided.
After obtaining the intermediate, it is reacted with L-glutamic acid diethyl ester in the presence of a catalyst in a suitable organic solvent. This step requires fine regulation of the reaction conditions, such as temperature, pH, etc., so that the two can be effectively combined.
After the reaction is completed, post-treatment operations such as extraction, washing, and drying are performed to remove impurities. At the end of the column chromatography or recrystallization method, the product can be purified with high purity of N - [4 - [2 - hydroxy - 4,7 - dioxo - 4 - oxo - 3H - imidazolo [2,3 - d] pyrimidine - 5 - yl) ethyl] benzyl] - L - glutamic acid, 1,5 - diethyl ester, 4 - methyl benzyl ester (1:1). Each step of the reaction needs to abide by the experimental procedures, strictly test the reaction process and product purity, in order to achieve the ideal preparation effect.
What is the market outlook for N- [4- [2- (2-amino-4,7-dihydro-4-oxo-3H-pyrrolido [2,3-d] pyrimidine-5-yl) ethyl] benzoyl] -L-glutamic acid, 1,5-diethyl ester, 4-methylbenzenesulfonate (1:1)
This is a rather complex chemical substance related inquiry. To clarify the market prospects of N - [4 - [2 - (2 - hydroxy - 4,7 - dioxide - 4 - oxo - 3H - pyrrolio [2,3 - d] pyrimidine - 5 - yl) ethyl] benzyl] - L - glutamine, 1,5 - diethyl ester, 4 - methyl benzyl ester (1:1), the following is a detailed analysis of you.
This chemical substance has a unique structure and may have potential applications in the field of pharmaceutical research and development. In pharmaceutical chemistry, compounds with complex structures are often key intermediates for the development of new drugs. If their pharmacological activities are confirmed by research, they may become innovative drugs for the treatment of specific diseases, which will generate a broad market demand.
In the field of life science research, such compounds may be used as biological probes to help scientists explore specific biochemical processes and molecular mechanisms in organisms. With the vigorous development of life science research, the demand for specific biological probes is increasing. If this compound can meet the relevant needs, it will also be favored by the market.
However, its market prospects are also facing challenges. The process of synthesizing such complex compounds may be complicated and expensive, which may limit their large-scale production and application. And the development of new drugs requires long and rigorous clinical trials to confirm their safety and effectiveness, a process full of uncertainties and high risks.
Overall, N - [4 - [2 - (2 - hydroxy - 4,7 - oxo - 4 - 3H - pyrrolido [2,3 - d] pyrimidine - 5 - yl) ethyl] benzyl] - L - glutamine, 1,5 - diethyl ester, 4 - methyl benzyl ester (1:1) has addressable market opportunities, but also need to overcome the synthesis and research and development and many other problems in order to fully realize its market value.